Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obstructive Lung Diseases
  Free Subscription

Articles published in
Arch Bronconeumol
    May 2026
  1. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Valverde-Molina J
    News From the Severe Asthma Consensus 2025 Review.
    Arch Bronconeumol. 2026;62:291-293.
    >> Share

  2. DE MIGUEL-DIEZ J, Suarez-Llanos JP, Figueira-Goncalves JM, Breton-Lesmes I, et al
    SEPAR and SEEN Consensus Document on Nutritional Assessment and Management in Patients with COPD.
    Arch Bronconeumol. 2026;62:325-338.
    >> Share

    April 2026
  3. TIOTIU A, Guidos Fogelbach G, Chong-Neto HJ, Novakova P, et al
    Impact of Biologics Administered for Severe Asthma on T2-comorbidities: A Narrative Review.
    Arch Bronconeumol. 2026 Apr 24:S0300-2896(26)00150.
    >> Share

  4. PEDRO-TUDELA A, Garcia-Ortega A, Martinez-Moragon E
    Pasteurella canis Pneumonia in a Severe Asthmatic Receiving Biologic Therapy: A Zoonotic Complication of Pet-related Anthropomorphism.
    Arch Bronconeumol. 2026 Apr 24:S0300-2896(26)00156.
    >> Share

  5. SORIANO JB, Lopez-Campos JL
    The World's Burden of Chronic Respiratory Disease: An Epidemiological Review of Asthma, COPD, Interstitial Lung Disease, and Smoking in the 21st Century.
    Arch Bronconeumol. 2026 Apr 23:S0300-2896(26)00151.
    >> Share

  6. GALERA R, Casitas R, Gavilan A, Redondo S, et al
    Which FEV(1) Decline Index Best Predicts Mortality in COPD? A 15-year Cohort Study.
    Arch Bronconeumol. 2026;62:217-225.
    >> Share

    March 2026
  7. LI B, Ji X, Xiang Z, Zhao F, et al
    CD126(+) Central Memory CD8(+) T Cells Are Enriched in the Airway in Asthma and Associated With Disease Severity.
    Arch Bronconeumol. 2026 Mar 22:S0300-2896(26)00107.
    >> Share

    February 2026
  8. CASTELLANOS LOPEZ L, Mira Palomino C, Raboso Moreno B
    Successful Management of Chronic Achromobacter xylosoxidans Bronchial Infection With Nebulized Levofloxacin in a Patient With Non-cystic Fibrosis Bronchiectasis.
    Arch Bronconeumol. 2026 Feb 16:S0300-2896(26)00078.
    >> Share

  9. HALPIN DMG, Masekela R, Vogelmeier CF, Ozoh OB, et al
    Addressing the Global Challenges of COPD and Asthma: A Shared Vision from the Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) and the Global Initiative for Asthma (GINA).
    Arch Bronconeumol. 2026;62:113-117.
    >> Share

  10. ROFFEL MP, Brandsma CA, Faiz A, Jonker MR, et al
    The Role of miR-320d in Regulation of Cigarette Smoke-Induced Pro-Inflammatory Responses in COPD.
    Arch Bronconeumol. 2026;62:86-93.
    >> Share

    January 2026
  11. TRAMONTANO A, Caporaso M, Macciocchi G, Simonetta E, et al
    New Perspectives in the Treatment of Bronchiectasis.
    Arch Bronconeumol. 2026 Jan 9:S0300-2896(26)00004.
    >> Share

  12. GOROSPE L, Chamorro-Perez J, Mirambeaux-Villalona RM
    Emphysematous Subcarinal Lymphadenitis Complicated With Pleural Empyema: Successful Management With Antibiotic Therapy and Percutaneous Drainage.
    Arch Bronconeumol. 2026 Jan 8:S0300-2896(26)00002.
    >> Share

  13. SOLER-CATALUNA JJ, Villagrasa M, Catalan P, Alcazar-Navarrete B, et al
    Risk validation of a new quantitative score for clinical control of chronic obstructive pulmonary disease: The RADAR score.
    Arch Bronconeumol. 2026;62:28-34.
    >> Share

  14. CASANOVA C, Gonzalez-Davila E, de Torres JP, Cabrera C, et al
    Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD.
    Arch Bronconeumol. 2026;62:20-27.
    >> Share

  15. DENG Z, Wu F, Wan Q, Dai C, et al
    Impaired Ventilatory Efficiency Identifies High-Risk Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2026;62:10-19.
    >> Share

  16. MORENO-ZABALETA R, Lujan Torne M, Sayas Catalan J, Garcia Torres P, et al
    SEPAR Position Paper on the Use of High Flow Nasal Cannula Therapy in the Home Setting.
    Arch Bronconeumol. 2026;62:35-43.
    >> Share

    December 2025
  17. SEGHERS-CARRERAS C, Jimenez-Gomez M, Diaz-Campos RM
    Severe Asthma Unresponsive to Therapy as the Initial Presentation of Pulmonary Venous Drainage Obstruction.
    Arch Bronconeumol. 2025 Dec 23:S0300-2896(25)00438.
    >> Share

  18. DIAZ-CAMPOS R, Jimenez-Gomez M, Cisneros-Serrano C, Trisan-Alonso A, et al
    Exhaled Volatile Organic Compounds as Potential Biomarkers of Exacerbation Risk in Asthma.
    Arch Bronconeumol. 2025 Dec 22:S0300-2896(25)00441.
    >> Share

  19. MARTINEZ-GARCIA MA, Aksamit T, Asakura T, Burr L, et al
    The Worldwide Puzzle of Bronchiectasis Etiology in Adults.
    Arch Bronconeumol. 2025 Dec 4:S0300-2896(25)00419.
    >> Share

  20. ALMONACID C, Quirce S, Blanco M, Del Cubillo A, et al
    Inside GEMA 5.5: Expert Insights on the Latest Changes in Asthma Management.
    Arch Bronconeumol. 2025 Dec 2:S0300-2896(25)00418.
    >> Share

  21. MIRAVITLLES M, Calle M, Molina J, Almagro P, et al
    Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD.
    Arch Bronconeumol. 2025;61:766-782.
    >> Share

    November 2025
  22. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Valverde-Molina J
    News From the Severe Asthma Consensus 2025 Review.
    Arch Bronconeumol. 2025 Nov 14:S0300-2896(25)00409.
    >> Share

  23. ORDONEZ GOMEZ P, Minana MD, Garcia-Ballesteros C, Signes-Costa J, et al
    Immune Gene Polymorphisms and Lung Cancer Risk in Chronic Obstructive Pulmonary Disease with Emphysema.
    Arch Bronconeumol. 2025 Nov 4:S0300-2896(25)00388.
    >> Share

  24. SINGH D, Menendez Lobo A, Higham A, Alcazar Navarrete B, et al
    Biological Therapy in COPD Management: Current Evidence, Challenges and Opportunities.
    Arch Bronconeumol. 2025;61:690-696.
    >> Share

    October 2025
  25. SOLARAT B, Mendoza N, Perea L, Amaro R, et al
    Systemic Immune Dysregulation in Patients With Bronchiectasis and Chronic Pseudomonas aeruginosa Infection.
    Arch Bronconeumol. 2025 Oct 25:S0300-2896(25)00382.
    >> Share

  26. DE-TORRES JP, Wilson DO, Wisnivesky JP, Salvatore MM, et al
    Chronic Respiratory Diseases and Lung Cancer Risk.
    Arch Bronconeumol. 2025 Oct 25:S0300-2896(25)00383.
    >> Share

  27. SANZ-FRAILE H, Herrero-Cortina B, Rovira-Ribalta N, Fernandez-Barat L, et al
    From Colour to Mechanics: A Dual Biomarker for Bronchiectasis Sputum.
    Arch Bronconeumol. 2025 Oct 4:S0300-2896(25)00340.
    >> Share

  28. HAMMADI A, Hoyas-Sanchez C, Romero-Linares A, Alvarez-Muro L, et al
    All-Cause and Cardiovascular Mortality With Single Inhaler Triple Therapy Versus Double Therapies for COPD: A Systematic Review and Metanalysis.
    Arch Bronconeumol. 2025;61:594-602.
    >> Share

    September 2025
  29. ADRISH M, Hanania NA
    Inflammation Without Borders: The Interconnected Pathways of Asthma and Heart Disease.
    Arch Bronconeumol. 2025 Sep 22:S0300-2896(25)00338.
    >> Share

  30. MCSHANE PJ
    Are Dipeptidyl Peptidase-1 Inhibitors the Future Anti-inflammatory Treatment in Bronchiectasis?
    Arch Bronconeumol. 2025 Sep 12:S0300-2896(25)00312.
    >> Share

  31. ZHOU Y, Wu F, Li H, Deng Z, et al
    Effect of Carbocysteine on Exacerbations and Lung Function in Patients With Mild-to-Moderate Chronic Obstructive Pulmonary Disease: A Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial.
    Arch Bronconeumol. 2025;61:528-535.
    >> Share

  32. PADILLA JM, Alfaro E, Casitas R, Galera R, et al
    Characterization of Inactive COPD Patients: Barriers to Physical Activity and Perceived Impact of Inactivity.
    Arch Bronconeumol. 2025;61:555-563.
    >> Share

  33. SAYAS CATALAN J, Lalmolda C, Hernandez-Voth A, Corral Blanco M, et al
    Thoracoabdominal Asynchrony in Very Severe COPD: Clinical and Functional Correlates During Exercise.
    Arch Bronconeumol. 2025;61:544-554.
    >> Share

  34. ARTEAGA M, Lopez-Duque L, Laorden D, Torrado I, et al
    Inhaled Corticosteroid Reduction Effects on Asthma Outcomes After Three Years of Benralizumab Treatment in Severe Asthma Patients.
    Arch Bronconeumol. 2025 Sep 1:S0300-2896(25)00299.
    >> Share

    August 2025
  35. GIMENO-SANTOS E, Vilaro J, Arbilllaga-Etxarri A, Herrero-Cortina B, et al
    Development and Comparison of Reference Equations for the Six-Minute Walk Test in Spanish Healthy Adults Aged 45-85 Years.
    Arch Bronconeumol. 2025;61:459-466.
    >> Share

    July 2025
  36. CHANG Q, Zhu Y, Liang H, Liu B, et al
    Association of Plasma Metabolic Profiling With Asthma Phenotypes and Exacerbation.
    Arch Bronconeumol. 2025 Jul 29:S0300-2896(25)00268.
    >> Share

  37. BETANCOR D, Rial MJ, Olaguibel JM, Del Pozo V, et al
    Stability of Asthma Biomarkers Over a Two-year Period Using Three Distinct Classifications in the MEGA Cohort.
    Arch Bronconeumol. 2025 Jul 5:S0300-2896(25)00230.
    >> Share

    June 2025
  38. LI XS, Gao YH
    Rethinking Pseudomonas aeruginosa in Bronchiectasis.
    Arch Bronconeumol. 2025 Jun 23:S0300-2896(25)00223.
    >> Share

  39. KING PT
    Childhood Pulmonary Virus Infection and Future Bronchiectasis.
    Arch Bronconeumol. 2025 Jun 7:S0300-2896(25)00213.
    >> Share

  40. LU L, Wan Q, Tang G, Wu F, et al
    New Classifications of COPD Severity Based on Impulse Oscillometry: A SAIO Grade Base on ECOPD Cohort in China.
    Arch Bronconeumol. 2025;61:334-340.
    >> Share

    May 2025
  41. MAC AOGAIN M, Chotirmall SH
    Antimicrobial Resistance and Pathobionts in Bronchiectasis: An Old Problem for a New Era?
    Arch Bronconeumol. 2025 May 16:S0300-2896(25)00183.
    >> Share

  42. VAN DER MOLEN MC, Posthuma R, Vaes AW, Spruit MA, et al
    Metabolic Changes After Bronchoscopic Lung Volume Reduction With Endobronchial Valves in COPD Patients.
    Arch Bronconeumol. 2025;61:282-289.
    >> Share

  43. CASAL-GUISANDE M, Represas-Represas C, Golpe R, Fernandez-Garcia A, et al
    Clinical and Social Characterization of Patients Hospitalized for COPD Exacerbation Using Machine Learning Tools.
    Arch Bronconeumol. 2025;61:264-273.
    >> Share

  44. GOLPE R, Veiga I, Dacal-Rivas D, Blanco-Cid N, et al
    Blood Eosinophil Count During Severe Bronchiectasis Exacerbation and Risk of Hospital Readmission.
    Arch Bronconeumol. 2025 May 1:S0300-2896(25)00156.
    >> Share

    April 2025
  45. MAROTO E, Esteban Lombarte MDM, Garriga-Baraut T, Garcia Del Cerro G, et al
    Efficacy of a Digitally Supported Intervention for Children and Adolescents With Difficult-to-control Asthma (INSPIRINGKIDS): Results From a Multicentre Randomized Controlled Trial.
    Arch Bronconeumol. 2025 Apr 28:S0300-2896(25)00140.
    >> Share

  46. DACAL RIVAS D, Martinez-Moragon E, Plaza V, Cisneros Serrano C, et al
    Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study.
    Arch Bronconeumol. 2025 Apr 26:S0300-2896(25)00139.
    >> Share

  47. GARCIA-OLIVE I, Radua J, Hernandez Biette A, Bruguera N, et al
    Evaluating the Utility of Biologic Therapies in Patients With Severe Asthma and Comorbid Bronchiectasis: A Systematic Review With Meta-analysis of Retrospective Studies.
    Arch Bronconeumol. 2025 Apr 26:S0300-2896(25)00149.
    >> Share

  48. MUNOZ-SANCHEZ B, Leon-Lloreda A, Romero-Falcon A, Medina-Gallardo JF, et al
    Identification of Fractional Exhaled Nitric Oxide Cutoff Values for the Diagnosis of Asthma.
    Arch Bronconeumol. 2025 Apr 2:S0300-2896(25)00121.
    >> Share

  49. OSCULLO G, Mendez R, Olveira C, Giron R, et al
    Effect of N-Acetylcysteine on Bronchiectasis in a Real-life Study. Data From the Spanish RIBRON Registry.
    Arch Bronconeumol. 2025;61:196-202.
    >> Share

    March 2025
  50. RODRIGUEZ-CHIARADIA DA, Torres-Castro R, Piccari L, Garcia-Ortega A, et al
    A Systematic Review and Expert Recommendation on the Diagnosis of Pulmonary Hypertension Associated With Lung Disease: A Position Paper of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR).
    Arch Bronconeumol. 2025 Mar 28:S0300-2896(25)00112.
    >> Share

  51. MARTIN-GONZALEZ E, Perez-Garcia J, Martin-Almeida M, Hernandez-Perez JM, et al
    Genome-wide Association Study of Asthma Exacerbations in the Spanish Population.
    Arch Bronconeumol. 2025 Mar 20:S0300-2896(25)00091.
    >> Share

  52. FERNANDEZ-BARAT L, Lopez-Aladid R, Alcaraz-Serrano V, Vazquez N, et al
    Clinical and Lung Microbiome Impact of Chronic Versus Intermittent Pseudomonas aeruginosa Infection in Bronchiectasis.
    Arch Bronconeumol. 2025 Mar 18:S0300-2896(25)00082.
    >> Share

  53. JIN KN, Lee HJ, Park H, Lee JK, et al
    Mucus Plugs as Precursors to Exacerbation and Lung Function Decline in COPD Patients.
    Arch Bronconeumol. 2025;61:138-146.
    >> Share

  54. BETANCOR D, Olaguibel JM, Del Pozo V, Alvarez Puebla MJ, et al
    FEV(1)Q as a Predictive Metric for Asthma Outcomes.
    Arch Bronconeumol. 2025 Mar 1:S0300-2896(25)00072.
    >> Share

    February 2025
  55. OSCULLO G, Bekki A, Olveira C, Giron R, et al
    Persistent Blood Eosinophilia and Eosinopenia: Relationship with Outcomes in Bronchiectasis.
    Arch Bronconeumol. 2025 Feb 4:S0300-2896(25)00043.
    >> Share

  56. BERNABEU-MORA R, Valera-Novella E, Bernabeu-Serrano ET, Soler-Cataluna JJ, et al
    Five-Repetition Sit-to-Stand Test as Predictor of Mortality in High Risk COPD Patients.
    Arch Bronconeumol. 2025;61:90-95.
    >> Share

    January 2025
  57. OSCULLO G, Bekki A, Martinez-Garcia MA
    Microbiome, Metabolome and Complexity in Bronchiectasis: The Future is Here.
    Arch Bronconeumol. 2025 Jan 31:S0300-2896(25)00033.
    >> Share

  58. ZHANG XX, He ZF, He JH, Chen ZM, et al
    Sputum Microbiota Correlates With Metabolome and Clinical Outcomes in Asthma-Bronchiectasis Overlap.
    Arch Bronconeumol. 2025 Jan 6:S0300-2896(25)00006.
    >> Share

  59. ROMERO FALCON MAA, Leon Lloreda A, Gomez-Bastero A
    Experience With the Use of Biological Therapy for Asthma Control During Pregnancy: Preliminary Results.
    Arch Bronconeumol. 2025 Jan 6:S0300-2896(25)00004.
    >> Share

  60. ERSOZ H, Torres-Duran M, Turner AM, Tanash H, et al
    Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry.
    Arch Bronconeumol. 2025;61:22-30.
    >> Share

    December 2024
  61. CHEN X, Li D, Ma Z
    A Commentary on 'Effect of the Antibody-Mediated Immune Responses on COPD, Asthma, and Lung Function: A Mendelian Randomization Study'.
    Arch Bronconeumol. 2024 Dec 5:S0300-2896(24)00454.
    >> Share

  62. ALVARADO-MIRANDA M, Solano A, Marsico S, Nunez-Robainas A, et al
    Clinical Implications of Functional Imaging in the Assessment of Bronchiectasis-Associated Sarcopenia.
    Arch Bronconeumol. 2024 Dec 4:S0300-2896(24)00453.
    >> Share

    November 2024
  63. ANSEDE-BORDONABA G, Giron-Moreno RM, Martinez-Vergara A
    Ulcerative Colitis, Bronchiectasis and Tofacitinib.
    Arch Bronconeumol. 2024 Nov 22:S0300-2896(24)00438.
    >> Share

  64. DE LUCA GR, Diciotti S, Mascalchi M
    The Pivotal Role of Baseline LDCT for Lung Cancer Screening in the Era of Artificial Intelligence.
    Arch Bronconeumol. 2024 Nov 22:S0300-2896(24)00439.
    >> Share

    October 2024
  65. GUIXING X, Yilin L, Huaying F, Fanrong L, et al
    Effect of the Antibody-mediated Immune Responses on COPD, Asthma, and Lung Function: A Mendelian Randomization Study.
    Arch Bronconeumol. 2024 Oct 22:S0300-2896(24)00406.
    >> Share

  66. PADILLA-GALO A, Rubio-Moreno M, Valencia-Azcona B
    Asthma-COPD Overlap - A Gateway to Biological Treatment.
    Arch Bronconeumol. 2024 Oct 22:S0300-2896(24)00409.
    >> Share

  67. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Soto-Campos G
    Reply to Letter: The Importance of Multidisciplinary Teams in the Evaluation of the Remission of Chronic Rhinosinusitis in Severe Asthma.
    Arch Bronconeumol. 2024 Oct 9:S0300-2896(24)00377.
    >> Share

  68. SCHILFARTH P, Maurac A, Macey J, Decloedt C, et al
    Sleep Quality in Patients Receiving Long-term NIV: A Prospective Cohort Study.
    Arch Bronconeumol. 2024;60:652-655.
    >> Share

  69. PINERO-GUTIERREZ P, Villar-Alvarez F, Asensio-Mathews P, Gonzalez-Peinado D, et al
    Organizing Pneumonia Secondary to ASIA Syndrome.
    Arch Bronconeumol. 2024;60:658-659.
    >> Share

  70. JO YS, Rhee CK, Kim SH, Lee H, et al
    Spirometric Transition of at Risk Individuals and Risks for Progression to Chronic Obstructive Pulmonary Disease in General Population.
    Arch Bronconeumol. 2024;60:634-642.
    >> Share

  71. KERGET B, Cinar I, Akdag BN, Yesilyurt M, et al
    New Indicators of Exercise Capacity and Respiratory Function in COPD Patients: The Role of Gastrocnemius Muscle Oxygenation and Elastography Levels.
    Arch Bronconeumol. 2024;60:643-645.
    >> Share

  72. KHO SS, Ing SK, Tie ST
    The Effect of Bronchoscopic Lung Volume Reduction on Hemidiaphragm Excursion.
    Arch Bronconeumol. 2024;60:668-669.
    >> Share

    September 2024
  73. PLAZA V, Garcia G, Perez de Llano L, Quirce S, et al
    Initiating Biological Treatment of Asthma: When is the Right Time?
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00364.
    >> Share

  74. TIOTIU CEPUC A, Steiropoulos P, Novakova S, Nedeva D, et al
    Airway Remodeling in Asthma: Mechanisms, Diagnosis, Treatment, and Future Directions.
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00367.
    >> Share

  75. TRAVERSI L, Garriga-Grimau L, Moreno-Galdo A, Polverino E, et al
    The In-between: Time to Talk About Bronchiectasis in Adolescents and Their Transition to Adult Care.
    Arch Bronconeumol. 2024 Sep 24:S0300-2896(24)00359.
    >> Share

  76. BARREIRO E, Gea J
    Muscle Fatigability of Patients With Severe COPD and Chronic Respiratory Failure: The Contribution of Respiratory Factors.
    Arch Bronconeumol. 2024;60:543-544.
    >> Share

  77. MALLAH N, Urbieta AD, Rivero-Calle I, Gonzalez-Barcala FJ, et al
    New Vaccines for Chronic Respiratory Patients.
    Arch Bronconeumol. 2024;60:565-575.
    >> Share

  78. VILLENEUVE T, Guilleminault L, Guibert N
    Sequential and Multimodal Bronchoscopic Interventions for COPD: Toward a Highly Personalized Interventional Pulmonology?
    Arch Bronconeumol. 2024;60:600-601.
    >> Share

    August 2024
  79. ALOBID I, Bernal-Sprekelsen M, Mullol J
    The Importance of Multidisciplinary Teams in the Evaluation of the Remission of Chronic Rhinosinusitis in Severe Asthma.
    Arch Bronconeumol. 2024 Aug 31:S0300-2896(24)00317.
    >> Share

  80. JACOME C, Jacome M, Correia S, Flores I, et al
    Effectiveness, Adherence and Safety of Home High Flow Nasal Cannula in Chronic Respiratory Disease and Respiratory Insufficiency: A Systematic Review.
    Arch Bronconeumol. 2024;60:490-502.
    >> Share

    July 2024
  81. GIL-MARTINEZ M, Rodrigo-Munoz JM, Antonio Canas J, Sastre J, et al
    Sputum Proteome Reveals Differences Between Eosinophilic and Non-eosinophilic Asthma Phenotypes.
    Arch Bronconeumol. 2024 Jul 20:S0300-2896(24)00273.
    >> Share

  82. WU X, Deng Z, Wu F, Zheng Y, et al
    Clinical Characteristics and 2-Year Outcomes of Chronic Obstructive Pulmonary Disease Patients With High Blood Eosinophil Counts: A Population-based Prospective Cohort Study in China.
    Arch Bronconeumol. 2024;60:402-409.
    >> Share

  83. AGUSTI A, Lopez-Campos JL, Miravitlles M, Soler-Cataluna JJ, et al
    Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial.
    Arch Bronconeumol. 2024;60:417-422.
    >> Share

  84. PANERONI M, Cavicchia A, Beatrice S, Bertacchini L, et al
    The Influence of Lung Function and Respiratory Muscle Strength on Quadriceps Muscle Fatigability in COPD Patients Under Long-term Oxygen Therapy.
    Arch Bronconeumol. 2024;60:410-416.
    >> Share

    June 2024
  85. COSIO BG, Shafiek H, Torrego A
    Bronchoscopy in Severe Asthmatics: Is it a Safe Procedure?
    Arch Bronconeumol. 2024 Jun 18:S0300-2896(24)00224.
    >> Share

  86. MA D, Munoz X, Ojanguren I, Romero-Mesones C, et al
    Increased TGFbeta1, VEGF and IFN-gamma in the Sputum of Severe Asthma Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Jun 7:S0300-2896(24)00221.
    >> Share

  87. DE MIGUEL-DIEZ J, Gomez Doblas JJ
    Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Response to Additional Considerations.
    Arch Bronconeumol. 2024;60:392-393.
    >> Share

  88. GOLPE R, Figueira-Goncalves JM
    Comment on "Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease".
    Arch Bronconeumol. 2024;60:391.
    >> Share

  89. FERNANDEZ-VILLAR A, Cimas Hernando JE, Figueira Goncalves JM, De Miguel Diez J, et al
    Continuity of Care in Chronic Obstructive Pulmonary Disease Exacerbations: Challenges and Priorities.
    Arch Bronconeumol. 2024;60:327-329.
    >> Share

    May 2024
  90. GONZALEZ J, Seijo LM, de-Torres JP, Benitez ID, et al
    Impact of OLD/Emphysema in LC Mortality Risk in Screening Programs: An Analysis of NLST and P-IELCAP.
    Arch Bronconeumol. 2024 May 16:S0300-2896(24)00170.
    >> Share

  91. GARRIGA-GRIMAU L, Sanz-Santiago V, Moreno-Galdo A
    Implementation of the Spanish Paediatric Bronchiectasis Registry (Child-BEAR-es Registry).
    Arch Bronconeumol. 2024 May 6:S0300-2896(24)00143.
    >> Share

  92. FORCADA BARREDA C, Fuentes Gago MG, Gomez Hernandez MT
    Subconjunctival Emphysema After Videothoracoscopic Segmentectomy.
    Arch Bronconeumol. 2024 May 4:S0300-2896(24)00138.
    >> Share

  93. BALLESTEROS-REVIRIEGO G, Arbillaga-Etxarri A, Marti JD
    Inspiratory Muscle Training: Back to Basics Must be the First Step?
    Arch Bronconeumol. 2024;60:267-268.
    >> Share

  94. PAPI A, Alfano F, Bigoni T, Mancini L, et al
    N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses.
    Arch Bronconeumol. 2024;60:269-278.
    >> Share

  95. CUENCA PERIS S, Martinez Tomas R, Briones Gomez A, Cases Viedma E, et al
    What to Do When Endobronchial Volume Reduction Treatment Fails.
    Arch Bronconeumol. 2024;60:319-320.
    >> Share

    April 2024
  96. CAKIR E, Ibis E, Yuzuak E
    Probable Invasive Aspergillosis Causing Massive Subcutaneous Emphysema by Rupturing the Pleura and Forming a Bronchopleural Fistula.
    Arch Bronconeumol. 2024 Apr 30:S0300-2896(24)00131.
    >> Share

  97. MASELLI DJ, Diaz AA
    Mortality Risk in Bronchiectasis.
    Arch Bronconeumol. 2024 Apr 24:S0300-2896(24)00114.
    >> Share

  98. ALVAREZ-GUTIERREZ FJ, Casas-Maldonado F, Soto-Campos G, Blanco-Aparicio M, et al
    Spanish Consensus on Remission in Asthma (REMAS).
    Arch Bronconeumol. 2024 Apr 23:S0300-2896(24)00109.
    >> Share

  99. PAN CX, He ZF, Lin SZ, Yue JQ, et al
    Clinical Characteristics and Outcomes of the Phenotypes of COPD-Bronchiectasis Association.
    Arch Bronconeumol. 2024 Apr 23:S0300-2896(24)00110.
    >> Share

  100. MAKRINIOTI H, Zhu Z, Saglani S, Camargo CA, et al
    Infant Bronchiolitis Endotypes and the Risk of Developing Childhood Asthma: Lessons From Cohort Studies.
    Arch Bronconeumol. 2024;60:215-225.
    >> Share

  101. DE MIGUEL-DIEZ J, Nunez Villota J, Santos Perez S, Manito Lorite N, et al
    Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease.
    Arch Bronconeumol. 2024;60:226-237.
    >> Share

    March 2024
  102. GAO YH, Zhu YN, Bai JW, Liang S, et al
    Severe Pulmonary Hypertension Increased All-cause Mortality in Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Mar 23:S0300-2896(24)00073.
    >> Share

  103. CHANG AB, Dharmage SC, Marchant JM, McCallum GB, et al
    Improving the Diagnosis and Treatment of Paediatric Bronchiectasis Through Research and Translation.
    Arch Bronconeumol. 2024 Mar 10:S0300-2896(24)00062.
    >> Share

  104. URRUTIA-ROYO B, Garcia-Olive I, Compte M, Folgado C, et al
    Effect of Comorbidities and Gender Differences in Survival in Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Mar 2:S0300-2896(24)00055.
    >> Share

  105. VITACCA M, Malovini A, Paneroni M, Spanevello A, et al
    Predicting Response to In-Hospital Pulmonary Rehabilitation in Individuals Recovering From Exacerbations of Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2024;60:153-160.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016